Toolkit/CheRiff

CheRiff

Construct Pattern·Research·Since 2014

Taxonomy: Mechanism Branch / Architecture. Workflows sit above the mechanism and technique branches rather than replacing them.

Summary

The web research summary states that the anchor paper full text explicitly names CheRiff as the engineered channelrhodopsin actuator spectrally orthogonal to QuasAr indicators.

Usefulness & Problems

Why this is useful

CheRiff is presented as the optogenetic actuator component used in the Optopatch platform. It provides light-driven stimulation for all-optical electrophysiology assays.; optical stimulation in all-optical electrophysiology; CheRiff is described in the supplied summary as the blue light-activated channelrhodopsin variant used in Optopatch constructs.; blue light-activated optical stimulation; CheRiff is described as an engineered channelrhodopsin actuator used for optical stimulation in the all-optical electrophysiology system.; optical stimulation of neurons; all-optical electrophysiology

Source:

CheRiff is presented as the optogenetic actuator component used in the Optopatch platform. It provides light-driven stimulation for all-optical electrophysiology assays.

Source:

optical stimulation in all-optical electrophysiology

Source:

CheRiff is described in the supplied summary as the blue light-activated channelrhodopsin variant used in Optopatch constructs.

Source:

blue light-activated optical stimulation

Source:

CheRiff is described as an engineered channelrhodopsin actuator used for optical stimulation in the all-optical electrophysiology system.

Source:

optical stimulation of neurons

Source:

all-optical electrophysiology

Problem solved

It supplies a non-electrode stimulation modality for optical electrophysiology workflows. This helps enable integrated stimulation-and-readout assays.; provides the stimulation component of the Optopatch assay; It provides the actuation half of an all-optical electrophysiology setup.; providing an optogenetic actuator component within all-optical electrophysiology systems; It supplies the stimulation arm of a combined optical stimulation and optical recording workflow.; providing an optogenetic actuator that can be paired with QuasAr indicators

Source:

It supplies a non-electrode stimulation modality for optical electrophysiology workflows. This helps enable integrated stimulation-and-readout assays.

Source:

provides the stimulation component of the Optopatch assay

Source:

It provides the actuation half of an all-optical electrophysiology setup.

Source:

providing an optogenetic actuator component within all-optical electrophysiology systems

Source:

It supplies the stimulation arm of a combined optical stimulation and optical recording workflow.

Source:

providing an optogenetic actuator that can be paired with QuasAr indicators

Problem links

provides the stimulation component of the Optopatch assay

Literature

It supplies a non-electrode stimulation modality for optical electrophysiology workflows. This helps enable integrated stimulation-and-readout assays.

Source:

It supplies a non-electrode stimulation modality for optical electrophysiology workflows. This helps enable integrated stimulation-and-readout assays.

providing an optogenetic actuator component within all-optical electrophysiology systems

Literature

It provides the actuation half of an all-optical electrophysiology setup.

Source:

It provides the actuation half of an all-optical electrophysiology setup.

providing an optogenetic actuator that can be paired with QuasAr indicators

Literature

It supplies the stimulation arm of a combined optical stimulation and optical recording workflow.

Source:

It supplies the stimulation arm of a combined optical stimulation and optical recording workflow.

Published Workflows

Objective: Enable all-optical electrophysiology in mammalian neurons using engineered microbial rhodopsins for optical stimulation and optical voltage recording in the same genetically targeted system.

Why it works: The source scaffold indicates that the platform pairs QuasAr voltage indicators with the CheRiff actuator and emphasizes spectral orthogonality and cross-talk-free operation.

microbial rhodopsin-based voltage-sensitive fluorescencechannelrhodopsin-based optical actuationall-optical electrophysiologycoexpression platform design

Taxonomy & Function

Primary hierarchy

Mechanism Branch

Architecture: A reusable architecture pattern for arranging parts into an engineered system.

Target processes

recombinationselection

Input: Light

Implementation Constraints

cofactor dependency: cofactor requirement unknownencoding mode: genetically encodedimplementation constraint: context specific validationimplementation constraint: spectral hardware requirementoperating role: sensorswitch architecture: split

Its use requires expression in the assay system and compatible optical stimulation hardware. In the supplied evidence it is paired with QuasAr voltage indicators.; used as part of the Optopatch platform; requires optical stimulation hardware; Its use requires optical illumination and expression in the target cells, and in the review context it is paired with a readout component such as QuasAr2.; used as a component within a larger optical electrophysiology construct context; Its use requires neuronal expression and illumination conditions suitable for optogenetic activation.; requires expression in mammalian neurons

standalone strengths and weaknesses relative to other actuators are not detailed in the supplied evidence; the provided review evidence does not include comparative performance claims

Validation

Cell-freeBacteriaMammalianMouseHumanTherapeuticIndep. Replication

Supporting Sources

Ranked Claims

Claim 1application scopesupports2017Source 2needs review

The review discusses bPAC as an optogenetic tool for cAMP control.

Claim 2application scopesupports2017Source 2needs review

The review discusses iGluSnFR as a neurotransmitter reporter relevant to synaptic function assays.

Claim 3application scopesupports2017Source 2needs review

The review discusses optoXRs as optogenetic tools for GPCR signaling in discovery-oriented applications.

Claim 4component compositionsupports2017Source 2needs review

The review describes Optopatch as pairing CheRiff with QuasAr voltage indicators.

Claim 5review scopesupports2017Source 2needs review

This review centers optogenetic and all-optical electrophysiology approaches for phenotypic screening in drug discovery.

Claim 6tool applicationsupports2016Source 3needs review

GCaMP6s is used in the review context as an activity reporter example for zebrafish brain imaging.

The anchor figure caption explicitly cites GCaMP6s for zebrafish brain activity imaging.
Claim 7tool applicationsupports2016Source 3needs review

LOVpep and ePDZ are presented in the review context as a light-induced intracellular trafficking control system.

The anchor figure caption names LOVpep and ePDZ in a light-induced trafficking example.
Claim 8tool composition or rolesupports2016Source 3needs review

Optopatch is presented in the review context as an all-optical electrophysiology system with CheRiff and QuasAr2 as named components.

PubMed figure captions ... explicitly mention tool/component names used in the review, especially Optopatch/CheRiff/QuasAr2.
Claim 9tool mechanismsupports2016Source 3needs review

pMag and nMag are presented in the review context as a light-induced dimerization pair used to reconstitute split Cas9 in photoactivatable genome editing.

The anchor figure caption names pMag as one half of the light-induced dimerization pair used to reconstitute split Cas9 ... nMag as the partner to pMag.
Claim 10component rolesupports2014Source 1needs review

CheRiff is an engineered channelrhodopsin actuator that is spectrally orthogonal to QuasAr indicators.

Claim 11component rolesupports2014Source 1needs review

QuasAr1 and QuasAr2 are evolved archaerhodopsin-based voltage indicators named as core components of the anchor paper.

Claim 12system capabilitysupports2014Source 1needs review

Optopatch is a coexpression platform enabling cross-talk-free genetically targeted all-optical electrophysiology.

Claim 13tool introductionsupports2014Source 1needs review

This paper presents all-optical electrophysiology in mammalian neurons using engineered microbial rhodopsins.

Approval Evidence

3 sources4 linked approval claimsfirst-pass slug cheriff
The review explicitly centers optogenetic/all-optical electrophysiology for phenotypic screening, especially the Optopatch platform pairing CheRiff with QuasAr voltage indicators.

Source:

The supplied web research summary states that PubMed figure captions for the anchor review explicitly name CheRiff as part of Optopatch.

Source:

The web research summary states that the anchor paper full text explicitly names CheRiff as the engineered channelrhodopsin actuator spectrally orthogonal to QuasAr indicators.

Source:

component compositionsupports

The review describes Optopatch as pairing CheRiff with QuasAr voltage indicators.

Source:

tool composition or rolesupports

Optopatch is presented in the review context as an all-optical electrophysiology system with CheRiff and QuasAr2 as named components.

PubMed figure captions ... explicitly mention tool/component names used in the review, especially Optopatch/CheRiff/QuasAr2.

Source:

component rolesupports

CheRiff is an engineered channelrhodopsin actuator that is spectrally orthogonal to QuasAr indicators.

Source:

tool introductionsupports

This paper presents all-optical electrophysiology in mammalian neurons using engineered microbial rhodopsins.

Source:

Comparisons

Source-stated alternatives

The supplied review scaffold does not name specific alternative actuators in the same sentence, but it places CheRiff within a broader optogenetic toolkit.; The same summary also mentions Channelrhodopsin-2 as another explicitly named optogenetic actuator in the review context.; The source scaffold contrasts it functionally with QuasAr indicators, which provide the recording arm rather than actuation.

Source:

The supplied review scaffold does not name specific alternative actuators in the same sentence, but it places CheRiff within a broader optogenetic toolkit.

Source:

The same summary also mentions Channelrhodopsin-2 as another explicitly named optogenetic actuator in the review context.

Source:

The source scaffold contrasts it functionally with QuasAr indicators, which provide the recording arm rather than actuation.

Source-backed strengths

identified as a core actuator component in a central assay platform; explicitly identified as a component in a named all-optical electrophysiology system; described as spectrally orthogonal to QuasAr indicators

Source:

identified as a core actuator component in a central assay platform

Source:

explicitly identified as a component in a named all-optical electrophysiology system

Source:

described as spectrally orthogonal to QuasAr indicators

Compared with optogenetic

The supplied review scaffold does not name specific alternative actuators in the same sentence, but it places CheRiff within a broader optogenetic toolkit.; The same summary also mentions Channelrhodopsin-2 as another explicitly named optogenetic actuator in the review context.

Shared frame: source-stated alternative in extracted literature

Strengths here: identified as a core actuator component in a central assay platform; explicitly identified as a component in a named all-optical electrophysiology system; described as spectrally orthogonal to QuasAr indicators.

Relative tradeoffs: standalone strengths and weaknesses relative to other actuators are not detailed in the supplied evidence; the provided review evidence does not include comparative performance claims.

Source:

The supplied review scaffold does not name specific alternative actuators in the same sentence, but it places CheRiff within a broader optogenetic toolkit.

Source:

The same summary also mentions Channelrhodopsin-2 as another explicitly named optogenetic actuator in the review context.

Compared with optogenetic actuator

The same summary also mentions Channelrhodopsin-2 as another explicitly named optogenetic actuator in the review context.

Shared frame: source-stated alternative in extracted literature

Strengths here: identified as a core actuator component in a central assay platform; explicitly identified as a component in a named all-optical electrophysiology system; described as spectrally orthogonal to QuasAr indicators.

Relative tradeoffs: standalone strengths and weaknesses relative to other actuators are not detailed in the supplied evidence; the provided review evidence does not include comparative performance claims.

Source:

The same summary also mentions Channelrhodopsin-2 as another explicitly named optogenetic actuator in the review context.

Ranked Citations

  1. 1.
    StructuralSource 1Nature Methods2014Claim 10Claim 11Claim 12

    Seeded from load plan for claim claim_1. Extracted from this source document.

  2. 2.
    StructuralSource 2Trends in biotechnology2017Claim 1Claim 2Claim 3

    Seeded from load plan for claim clm_2. Extracted from this source document.

  3. 3.
    StructuralSource 3Biophysical Journal2016Claim 6Claim 7Claim 8

    Extracted from this source document.